Developer docs
API playgroundTry for free, no card

Search company profiles

BioVendor Group

Full company profile

uuid000aokn

Namestring
BioVendor Group
Legal namestring
BioVendor – Laboratorni medicina s.r.o.
Websiteurl
biovendor.com
Company typeenum
Private
Founded yearint
1992
Descriptiontext

BioVendor Group is a privately-held international group of biotechnology companies headquartered in Brno, Czech Republic, founded in 1992. The group develops, manufactures, and distributes in vitro diagnostic (IVD) products and technologies spanning multiple diagnostic modalities, including immunoassays (ELISA and CLIA kits), recombinant proteins, monoclonal and polyclonal antibodies, Next Generation Sequencing (NGS) cancer panels (fastGEN and epicGEN lines), endotoxin detection products (ENDONEXT™ EndoZyme®), PCR/qPCR reagents, point-of-care testing devices (Bi-Reader, Bi-VirTest), and immunohistochemistry reagents. The technology platform is anchored in immunoassay and recombinant protein production capabilities, with proprietary innovations such as SophoMer™ F10, a synthetic polymer intended to replace BSA in laboratory assays. The group operates through six wholly-owned subsidiary brands (BioVendor-LM, BioVendor-RD, TestLine, ViennaLab, DiaSource, BioVendor MDx) plus three joint projects (CLIA CZ, MBA Microblot-Array, NGS CZ), serving academic and pharmaceutical research laboratories, clinical diagnostic laboratories, and oncology testing facilities worldwide.

The business model is primarily a one-time product-sale model with unit-based pricing, predominantly for Research Use Only (RUO) reagents. Pricing signals indicate per-unit economics on the order of $231–$300 for ELISA kits and $243–$1,890 for antibodies. Go-to-market is executed through direct sales via the corporate website and email/phone ordering, supplemented by a dedicated US distribution branch (BioVendor, LLC), regional distributors in other geographies, and a marketing mix that emphasizes trade-show presence (e.g., ADLM 2026, WHX Labs Dubai 2026), corporate website content, email newsletters, and LinkedIn. Customer segmentation is horizontal across research institutions, clinical labs, and oncology testing; no named anchor customers or enterprise contracts are disclosed. The M&A track record (TestLine 2012, Immunolab 2014, DIAsource 2017) and a 2014 capital injection from Accession Capital Partners indicate a roll-up strategy supported by external capital.

Short descriptiontext

BioVendor Group is a privately-held Czech biotechnology group founded in 1992 that develops, manufactures, and distributes in vitro diagnostic products across immunoassays, NGS cancer panels, antibodies, recombinant proteins, and endotoxin detection, serving research and clinical laboratories worldwide through six subsidiary brands.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBrno, Czechia
HQ citystring
Brno
HQ countrystring
Czechia
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
in vitro diagnostics, immunoassay development, molecular diagnostics, recombinant proteins, antibody manufacturing
Industry3 codes
PRIMARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
In Vitro Diagnostics (IVD)
Revenue model1 record
1IVD Products and Technologies
TypeOne Time License
Description

Sale of immunodiagnostic and molecular diagnostic products including immunoassays, antibodies, recombinant proteins, NGS kits, and laboratory reagents to research institutions, diagnostic laboratories, and healthcare facilities

biovendor.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Pricing details4 tiers
1Human Fibrin Mouse Monoclonal Antibody - Research Use Only
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Sizes available: 0.01 mg ($974), 0.1 mg ($1125), 0.5 mg ($1890)

biovendor.com
2Cartilage Oligomeric Matrix Protein Human ELISA - Discount pricing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$300 per unit; Buy 2-5 pcs for $231 each; 6+ pcs on request only

biovendor.com
3Connective Tissue Growth Factor Human Antibodies
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Rabbit Polyclonal: $266 each (2-5 pcs); Sheep Polyclonal: $277 / $243 each

biovendor.com
4NT-proBNP Human, Sheep Polyclonal Antibody
ModelUnit PricingBilling cadencePay-as-you-go
Notes

0.1 mg: $277; 6+ pcs on request

biovendor.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1CLIA CZ
Description

Joint project focused on CLIA (chemiluminescence immunoassay) technology

biovendor.com
+2 more records
Core offering1 text field

BioVendor Group develops, manufactures, and distributes in vitro diagnostic (IVD) products and laboratory reagents for research and clinical diagnostics. Its portfolio spans immunoassays (ELISA, CLIA), Next Generation Sequencing (NGS) kits for cancer diagnostics, recombinant proteins, monoclonal and polyclonal antibodies, immunohistochemistry reagents, endotoxin detection assays, DNA/RNA extraction kits, qPCR reagents, and microRNA detection products. The group sells these validated diagnostic tools and laboratory reagents to research institutions, diagnostic laboratories, and healthcare facilities worldwide through multiple subsidiary brands.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

BioVendor Group is an international group of biotechnology companies focusing on the development, production, and distribution of IVD (In Vitro Diagnostic) products and technologies for laboratory automation. The product portfolio is organized into multiple core categories including Immunoassays (ELISA kits), Point of Care Testing (POCT), Next Generation Sequencing (NGS with fastGEN and epicGEN product lines), Proteins, Antibodies, Immunohistochemistry, Endotoxin Detection Products (ENDONEXT™), Tissue Engineering, DNA/RNA Extraction Kits, qPCR Reagents, and microRNA products. The offerings include both standalone reagent kits (like the Human COMP ELISA for cartilage research) and integrated solutions like the fully automated CLIA diabetes panel. The company serves research laboratories with validated diagnostic tools across immunoassays, molecular diagnostics, and Point of Care Testing segments.

Product and service6 records
1Immunoassays
CategoryImmunoassays / IVD Reagents
Description

Validated ELISA and CLIA immunoassay kits for quantitative measurement of biomarkers including diabetes markers (C-peptide, Insulin, GAD65, IA-2), cardiovascular markers, and inflammation markers. Used by clinical and research laboratories.

2Point of Care Testing (POCT)
CategoryPoint of Care Testing
Description

Rapid point-of-care diagnostic tests including Bi-VirTest for Human MxA POCT for quick clinical diagnostics, along with associated readers such as Bi-Reader.

3Next Generation Sequencing (NGS) Kits - fastGEN and epicGEN
CategoryMolecular Diagnostics
Description

NGS kits for cancer genotyping and molecular diagnostics including fastGEN Cancer Kits (MPN, EGFR/HER2, BCR::ABL1, MSI, H3F3A/IDH1/2, TERT, POLE/CTNNB1) and epicGEN Solid Cancer & MSI Kit. Used by cancer diagnostics laboratories.

4Recombinant Proteins
CategoryProteins / Reagents
Description

Recombinant proteins including SARS-CoV-2 Nucleocapsid Protein, Uromodulin Human HEK293, Luteinizing Hormone, and Coagulation Factor VIII for research use.

5Antibodies
CategoryAntibodies / Research Reagents
Description

Monoclonal and polyclonal antibodies including Human Fibrin, Human Fibrinogen, Connective Tissue Growth Factor, NT-proANP, and Neudesin antibodies for research applications including ELISA, Western blotting, immunohistochemistry, and flow cytometry.

6ENDONEXT™ EndoZyme® II Endotoxin Detection Products
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Peers10 records
TypeDirect peer
Description

Italian IVD multinational focused on immunodiagnostics and molecular diagnostics, with comparable CLIA and ELISA reagent menus and a similar specialty-diagnostics positioning that competes head-to-head with BioVendor's immunoassay catalog.

TypeDirect peer
Description

Global biotech reagent company offering recombinant proteins, antibodies, gene synthesis, and molecular diagnostics reagents; comparable to BioVendor across protein/antibody and qPCR reagent lines.

TypeDirect peer
Description

Specialist in autoimmune and infectious disease immunoassays, owned by Revvity; closely comparable to BioVendor's TestLine and BioVendor-LM subsidiaries in ELISA and Microblot-Array autoantibody testing.

4Merck KGaA / MilliporeSigma
TypeBroad incumbent
Description

Global life science tools and IVD reagent manufacturer with extensive antibody, protein, buffer, and assay kit portfolios; competes broadly with BioVendor across research reagent categories.

TypeBroad incumbent
Description

Large publicly traded life science and clinical diagnostics company with overlapping offerings in immunoassays, qPCR, NGS sample prep, and recombinant proteins; competes with BioVendor across multiple product categories but operates at vastly greater scale.

TypeDirect peer
Description

Major research antibody and recombinant protein supplier now owned by Danaher; directly competes with BioVendor-RD's antibody catalog and recombinant protein product lines in research applications.

TypeDirect peer
Description

Leading molecular diagnostics and sample-prep company with overlapping offerings in DNA/RNA extraction kits, qPCR reagents, and NGS-targeted panels; directly competes with BioVendor MDx's molecular diagnostic kits.

TypeDirect peer
Description

Provides IVD reagent chemistries and surface coatings used by diagnostic kit manufacturers, comparable in product category to BioVendor's reagent, antibody, and polymer reagent offerings for diagnostic workflows.

TypeBroad incumbent
Description

Swiss leader in lab automation and detection instruments (including CLIA readers used with BioVendor-type immunoassays); an incumbent whose automation platforms BioVendor kits run on, and which competes broadly for the lab reagent budget.

TypeDirect peer
Description

Provides IVD reagents, diagnostic controls, and assay components; comparable to BioVendor's reagent and consumables business serving clinical and research labs globally.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioVendor Group

In Vitro Diagnostics (IVD)biovendor.com

BioVendor Group is a privately-held Czech biotechnology group founded in 1992 that develops, manufactures, and distributes in vitro diagnostic products across immunoassays, NGS cancer panels, antibodies, recombinant proteins, and endotoxin detection, serving research and clinical laboratories worldwide through six subsidiary brands.

What BioVendor Group does

BioVendor Group is a privately-held international group of biotechnology companies headquartered in Brno, Czech Republic, founded in 1992. The group develops, manufactures, and distributes in vitro diagnostic (IVD) products and technologies spanning multiple diagnostic modalities, including immunoassays (ELISA and CLIA kits), recombinant proteins, monoclonal and polyclonal antibodies, Next Generation Sequencing (NGS) cancer panels (fastGEN and epicGEN lines), endotoxin detection products (ENDONEXT™ EndoZyme®), PCR/qPCR reagents, point-of-care testing devices (Bi-Reader, Bi-VirTest), and immunohistochemistry reagents. The technology platform is anchored in immunoassay and recombinant protein production capabilities, with proprietary innovations such as SophoMer™ F10, a synthetic polymer intended to replace BSA in laboratory assays. The group operates through six wholly-owned subsidiary brands (BioVendor-LM, BioVendor-RD, TestLine, ViennaLab, DiaSource, BioVendor MDx) plus three joint projects (CLIA CZ, MBA Microblot-Array, NGS CZ), serving academic and pharmaceutical research laboratories, clinical diagnostic laboratories, and oncology testing facilities worldwide.

The business model is primarily a one-time product-sale model with unit-based pricing, predominantly for Research Use Only (RUO) reagents. Pricing signals indicate per-unit economics on the order of $231–$300 for ELISA kits and $243–$1,890 for antibodies. Go-to-market is executed through direct sales via the corporate website and email/phone ordering, supplemented by a dedicated US distribution branch (BioVendor, LLC), regional distributors in other geographies, and a marketing mix that emphasizes trade-show presence (e.g., ADLM 2026, WHX Labs Dubai 2026), corporate website content, email newsletters, and LinkedIn. Customer segmentation is horizontal across research institutions, clinical labs, and oncology testing; no named anchor customers or enterprise contracts are disclosed. The M&A track record (TestLine 2012, Immunolab 2014, DIAsource 2017) and a 2014 capital injection from Accession Capital Partners indicate a roll-up strategy supported by external capital.

BioVendor Group firmographics

Firmographics
Name
BioVendor Group
Legal name
BioVendor – Laboratorni medicina s.r.o.
Website
https://biovendor.com
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
51–100 employees
Short description
BioVendor Group is a privately-held Czech biotechnology group founded in 1992 that develops, manufactures, and distributes in vitro diagnostic products across immunoassays, NGS cancer panels, antibodies, recombinant proteins, and endotoxin detection, serving research and clinical laboratories worldwide through six subsidiary brands.
Ownership category
akta.pro rank

BioVendor Group industry classification

Industry
Product category
In Vitro Diagnostics (IVD)
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • In vitro diagnostics
  • Immunoassay development
  • Molecular diagnostics
  • Recombinant proteins
  • Antibody manufacturing

Where BioVendor Group is headquartered

Location

Headquarters

HQ city
Brno
HQ country
Czechia
HQ region
Europe

Offices2 records

Markets served

BioVendor Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. IVD Products and Technologies: Sale of immunodiagnostic and molecular diagnostic products including immunoassays, antibodies, recombinant proteins, NGS kits, and laboratory reagents to research institutions, diagnostic laboratories, and healthcare facilities

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goHuman Fibrin Mouse Monoclonal Antibody - Research Use Only
Unit PricingPay-as-you-goCartilage Oligomeric Matrix Protein Human ELISA - Discount pricing
Unit PricingPay-as-you-goConnective Tissue Growth Factor Human Antibodies
Unit PricingPay-as-you-goNT-proBNP Human, Sheep Polyclonal Antibody

Distribution channels3 records

Marketing channels4 records

BioVendor Group product offering

Product offering

Core offering

BioVendor Group develops, manufactures, and distributes in vitro diagnostic (IVD) products and laboratory reagents for research and clinical diagnostics. Its portfolio spans immunoassays (ELISA, CLIA), Next Generation Sequencing (NGS) kits for cancer diagnostics, recombinant proteins, monoclonal and polyclonal antibodies, immunohistochemistry reagents, endotoxin detection assays, DNA/RNA extraction kits, qPCR reagents, and microRNA detection products. The group sells these validated diagnostic tools and laboratory reagents to research institutions, diagnostic laboratories, and healthcare facilities worldwide through multiple subsidiary brands.

Product overview

BioVendor Group is an international group of biotechnology companies focusing on the development, production, and distribution of IVD (In Vitro Diagnostic) products and technologies for laboratory automation. The product portfolio is organized into multiple core categories including Immunoassays (ELISA kits), Point of Care Testing (POCT), Next Generation Sequencing (NGS with fastGEN and epicGEN product lines), Proteins, Antibodies, Immunohistochemistry, Endotoxin Detection Products (ENDONEXT™), Tissue Engineering, DNA/RNA Extraction Kits, qPCR Reagents, and microRNA products. The offerings include both standalone reagent kits (like the Human COMP ELISA for cartilage research) and integrated solutions like the fully automated CLIA diabetes panel. The company serves research laboratories with validated diagnostic tools across immunoassays, molecular diagnostics, and Point of Care Testing segments.

Differentiator

Problem solved

Functional benefit

Brands

  • CLIA CZ: Joint project focused on CLIA (chemiluminescence immunoassay) technology
  • MBA
  • NGS CZ

Products and services

  • Immunoassays Validated ELISA and CLIA immunoassay kits for quantitative measurement of biomarkers including diabetes markers (C-peptide, Insulin, GAD65, IA-2), cardiovascular markers, and inflammation markers. Used by clinical and research laboratories.
  • Point of Care Testing (POCT) Rapid point-of-care diagnostic tests including Bi-VirTest for Human MxA POCT for quick clinical diagnostics, along with associated readers such as Bi-Reader.
  • Next Generation Sequencing (NGS) Kits - fastGEN and epicGEN NGS kits for cancer genotyping and molecular diagnostics including fastGEN Cancer Kits (MPN, EGFR/HER2, BCR::ABL1, MSI, H3F3A/IDH1/2, TERT, POLE/CTNNB1) and epicGEN Solid Cancer & MSI Kit. Used by cancer diagnostics laboratories.
  • Recombinant Proteins Recombinant proteins including SARS-CoV-2 Nucleocapsid Protein, Uromodulin Human HEK293, Luteinizing Hormone, and Coagulation Factor VIII for research use.
  • Antibodies Monoclonal and polyclonal antibodies including Human Fibrin, Human Fibrinogen, Connective Tissue Growth Factor, NT-proANP, and Neudesin antibodies for research applications including ELISA, Western blotting, immunohistochemistry, and flow cytometry.
  • ENDONEXT™ EndoZyme® II Endotoxin Detection Products

Companies that use BioVendor Group

Customer profile

Segments3 records

Ideal customer profiles3 records

BioVendor Group technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

BioVendor Group partnerships and signals

Strategic signal

Scale indicators2 records

BioVendor Group competitors and assessment

Company assessment

Direct peers

  • DiaSorin: Italian IVD multinational focused on immunodiagnostics and molecular diagnostics, with comparable CLIA and ELISA reagent menus and a similar specialty-diagnostics positioning that competes head-to-head with BioVendor's immunoassay catalog.
  • GenScript: Global biotech reagent company offering recombinant proteins, antibodies, gene synthesis, and molecular diagnostics reagents; comparable to BioVendor across protein/antibody and qPCR reagent lines.
  • Euroimmun (Revvity): Specialist in autoimmune and infectious disease immunoassays, owned by Revvity; closely comparable to BioVendor's TestLine and BioVendor-LM subsidiaries in ELISA and Microblot-Array autoantibody testing.
  • Abcam (Danaher): Major research antibody and recombinant protein supplier now owned by Danaher; directly competes with BioVendor-RD's antibody catalog and recombinant protein product lines in research applications.
  • Qiagen: Leading molecular diagnostics and sample-prep company with overlapping offerings in DNA/RNA extraction kits, qPCR reagents, and NGS-targeted panels; directly competes with BioVendor MDx's molecular diagnostic kits.
  • Surmodics / DiaPath (now part of broader portfolio): Provides IVD reagent chemistries and surface coatings used by diagnostic kit manufacturers, comparable in product category to BioVendor's reagent, antibody, and polymer reagent offerings for diagnostic workflows.
  • LGC Group (SeraCare/Meridian Bioscience): Provides IVD reagents, diagnostic controls, and assay components; comparable to BioVendor's reagent and consumables business serving clinical and research labs globally.

Broad incumbents

  • Merck KGaA / MilliporeSigma: Global life science tools and IVD reagent manufacturer with extensive antibody, protein, buffer, and assay kit portfolios; competes broadly with BioVendor across research reagent categories.
  • Bio-Rad Laboratories: Large publicly traded life science and clinical diagnostics company with overlapping offerings in immunoassays, qPCR, NGS sample prep, and recombinant proteins; competes with BioVendor across multiple product categories but operates at vastly greater scale.
  • Tecan: Swiss leader in lab automation and detection instruments (including CLIA readers used with BioVendor-type immunoassays); an incumbent whose automation platforms BioVendor kits run on, and which competes broadly for the lab reagent budget.

Market position

Strengths5 records

Weaknesses5 records

Key risks5 records

Key highlights6 records

Customer concentration

BioVendor Group social profiles

Digital presence

BioVendor Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioVendor Group leadership team

Management profile

Number of profiles

Profiles3 records

BioVendor Group subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

BioVendor Group funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioVendor Group M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioVendor Group

What does BioVendor Group do?

BioVendor Group develops, manufactures, and distributes in vitro diagnostic (IVD) products and laboratory reagents for research and clinical diagnostics. Its portfolio spans immunoassays (ELISA, CLIA), Next Generation Sequencing (NGS) kits for cancer diagnostics, recombinant proteins, monoclonal and polyclonal antibodies, immunohistochemistry reagents, endotoxin detection assays, DNA/RNA extraction kits, qPCR reagents, and microRNA detection products. The group sells these validated diagnostic tools and laboratory reagents to research institutions, diagnostic laboratories, and healthcare facilities worldwide through multiple subsidiary brands.

Is BioVendor Group a public or private company?

BioVendor Group is a private company. It is classified as private equity controlled and is currently operating.

When was BioVendor Group founded?

BioVendor Group was founded in 1992. It employs 51 to 100 people.

Where is BioVendor Group based?

BioVendor Group is headquartered in Brno, Czechia, in the Europe region.

How does BioVendor Group make money?

One revenue line is on record: IVD Products and Technologies.

Who are BioVendor Group's main competitors?

Direct peers on record are DiaSorin, GenScript, Euroimmun (Revvity), Abcam (Danaher), Qiagen, Surmodics / DiaPath (now part of broader portfolio) and LGC Group (SeraCare/Meridian Bioscience). Broad incumbents are Merck KGaA / MilliporeSigma, Bio-Rad Laboratories and Tecan.

Does BioVendor Group have an API?

No public API is recorded for BioVendor Group.

What industry is BioVendor Group in?

BioVendor Group's product category is In Vitro Diagnostics (IVD). Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
InvestorsinhealthcareCzech Republic: BioVendor Group partners with ArchimedArchimed, a global private equity healthcare specialist, acquired BioVendor Group, a developer and manufacturer of immunoassays, recombinant proteins, antibodies, and endotoxin-removal products. The acquisition expands Archimed's investments in diagnostics.ArchimedARCHIMED purchases BioVendor Group, a leading global player in advanced diagnosticsPrivate equity firm ARCHIMED has completed the acquisition of BioVendor Group, a leading global diagnostics company headquartered in the Czech Republic. This transaction expands ARCHIMED's portfolio in the diagnostics industry, building on previous successful investments such as DIESSE and Eurolyser. Existing management will remain in place while ARCHIMED deploys its MedValue growth template to accelerate BioVendor's internationalization and product expansion.PR NewswireBioVendor adquiere el 100% de las acciones de DIAsource ImmunoAssays SABioVendor - Laboratorní medicína a.s. acquired 100% of the shares of DIAsource ImmunoAssays SA from Anteo Diagnostics (ASX: ADO), completing the transaction on October 10, 2017. DIAsource, a 30-year-old Belgian diagnostics company headquartered in Louvain-la-Neuve with 80 employees, generated €16.3 million in net revenues and €3.4 million EBITDA in 2016 with double-digit growth over five years. The acquisition represents BioVendor's largest to date, expanding its portfolio with over 190 ELISA and 140 RIA assays while gaining direct presence in Belgium, France, and Spain plus access to distribution networks in over 70 countries.